No Data
No Data
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Leerink Partners Remains a Hold on Landos Biopharma (LABP)
AbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio
Sector Update: Health Care Stocks Softer in Afternoon Trading
Health care stocks were easing Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding about 0.2%. The iShares Biotechnology ETF (IBB) decreas
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Landos Biopharma, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - March 25, 2024) - Rigrodsky Law, P.A. is investigating Landos Biopharma, Inc. ("Landos") (NASDAQ: LABP) regarding possible breaches of fiduciary duties and othe
Landos (LABP) Secures AbbVie Deal: Propelling Novel Oral Therapy Development
The current surge of Landos Biopharma, Inc. (NASDAQ: LABP) shares on the US charts, marking a notable surge of 168.27% to $21.46 per share as of the last check, is attributed to a takeover bid. Today, Landos (LABP) disclosed a definitive agreement with AbbVie Inc., outlining AbbVie's intent to acquire Landos. At the forefront of ...
No Data